Valneva SE (FRA:AYJ) YoY EBITDA Growth : 588.30% (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Valneva SE YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Valneva SE's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 588.30%.

Valneva SE's EBITDA per Share for the three months ended in Mar. 2024 was €0.46.

Valneva SE YoY EBITDA Growth Historical Data

The historical data trend for Valneva SE's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE YoY EBITDA Growth Chart

Valneva SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-34.50

-540.18

19.47

-128.46

54.13

Valneva SE Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															51.04	90.78	-128.32	58.88	588.30

Valneva SE YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Valneva SE's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.416	-	-0.907)	/	\| -0.907 \|
=	54.13 %

Valneva SE's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(0.459	-	-0.094)	/	\| -0.094 \|
=	588.30 %

Valneva SE YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Valneva SE's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Valneva SE (FRA:AYJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (FRA:AYJ) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

VALN:USA INRLF:USA VLA:France AYJ:Germany VLA:Austria

Address

6 Rue Alain Bombard, Saint-Herblain, FRA, 44800

Website

https://www.valneva.com

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, & third-party products; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The majority is from the Commercialized vaccines segment & geographically from the United States.

Valneva SE (FRA:AYJ) Headlines

No Headlines